Abstract:Abstract Background Recent data indicated that macrophages may mutually interact with cancer cells to promote tumor progression and chemoresistance, but the interaction in cholangiocarcinoma (CCA) is obscure. Methods 10x Genomics single-cell sequencing technology was used to identified the role of macrophages in CCA. Then, we measured the expression and prognostic role of macrophage markers and aPKC ɩ in 70 human CCA tissues. Moreover, we constructed monocyte-derived macrophages (MDMs) generated from peripheral blood monocytes (PBMCs) and polarized them into M1/M2 macrophages. A co-culture assay of the human CCA cell lines (TFK-1, EGI-1) and differentiated PBMCs-macrophages was established, and functional studies in vitro and in vivo was performed to explore the interaction between cancer cells and M2 macrophages. Furthermore, we established the cationic liposome-mediated co-delivery of gemcitabine and aPKC ɩ -siRNA and detect the antitumor effects in CCA. Results M2 macrophage showed tumor-promoting properties in CCA. High levels of aPKC ɩ expression and M2 macrophage infiltration were associated with metastasis and poor prognosis in CCA patients. Moreover, CCA patients with low M2 macrophages infiltration or low aPKC ɩ expression benefited from postoperative gemcitabine-based chemotherapy. Further studies showed that M2 macrophages-derived TGFβ1 induced epithelial-mesenchymal transition (EMT) and gemcitabine resistance in CCA cells through aPKC ɩ -mediated NF-κB signaling pathway. Reciprocally, CCL5 was secreted more by CCA cells undergoing aPKC ɩ -induced EMT and consequently modulated macrophage recruitment and polarization. Furthermore, the cationic liposome-mediated co-delivery of GEM and aPKC ɩ -siRNA significantly inhibited macrophages infiltration and CCA progression. Conclusion our study demonstrates the role of Macrophages-aPKC ɩ -CCL5 Feedback Loop in CCA, and proposes a novel therapeutic strategy of aPKC ɩ -siRNA and GEM co-delivered by liposomes for CCA.

Tumor-associated macrophages: orchestrators of cholangiocarcinoma progression

Tumor Microenvironment and Its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies

Tumor-Associated Macrophages in Tumor Immunity (vol <i>11</i>, <i>583084</i>, <i>2020</i>)

Cholangiocarcinoma tumor microenvironment highlighting fibrosis and matrix components

The Tumor Immune Microenvironment plays a Key Role in Driving the Progression of CholangioCarcinoma

The Role of Tumour Microenvironment: a New Vision for Cholangiocarcinoma

Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma

Macrophages-aPKCɩ-CCL5 Feedback Loop Modulates the Progression and Chemoresistance in Cholangiocarcinoma

Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe?

Tumor-associated macrophages: an accomplice in solid tumor progression

Therapeutic significance of tumor microenvironment in cholangiocarcinoma: focus on tumor-infiltrating T lymphocytes

Unveiling the contribution of tumor-associated macrophages in driving epithelial-mesenchymal transition: a review of mechanisms and therapeutic Strategies

Tumor‑associated macrophages activated in the tumor environment of hepatocellular carcinoma: Characterization and treatment (Review)

The role of tumor‐associated macrophages in hepatocellular carcinoma progression: A narrative review

Exploring the Tumor Promoting Role of Anti-Tumor Macrophage: a Developmental Perspective

Tumor-associated macrophages in colorectal cancer metastasis: molecular insights and translational perspectives

Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy

Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review)

[The Role of Tumor-Associated Macrophages in the Development and Progression of Cervical Cancer].

Tumor-associated macrophages promote epithelial–mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling

Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis